Statin drugs are normally used to treat high cholesterol. Now, research shows that they may also help multiple sclerosis (MS) patients manage their disease.

Acceleron Pharma, Inc. has announced receipt of a $1.5 million grant awarded from the Muscular Dystrophy Association (MDA) to support clinical studies of the therapy ACE-031.

An international team of researchers headed by an investigator from Fred Hutchinson Cancer Research Center have made a critical advance in determining the cause of a common form of muscular dystrophy.

A new study suggests efforts to determine the nutritional effect on Alzheimer's disease could be improved by using nutrient “biomarkers” in elderly people at risk for dementia.

Pharmaceutical company Novartis AG's multiple sclerosis (MS) drug, Gilenya, has been approved for use in the United States and now Europe to treat relapsing-remitting forms of the disease.

Swedish researchers have found that damaged alpha-synuclein proteins can spread in Parkinson's disease similar to an infection model found in conditions like mad cow disease.

Deep brain stimulation has proven beneficial for some treatment-resistant cases of obsessive-compulsive disorder (OCD), depressive disorders and Tourette syndrome.

Patients with Parkinson's disease find it more difficult to gauge and recognize expressions of emotion in other people's faces and voices, according to new research.

Eating a handful of pecans every day may provide protection against the progression of motor neuron degeneration due to age or possibly even diseases like amyotrophic lateral sclerosis (ALS).

Adults with fibromyalgia are more likely to experience restless legs syndrome (RLS), according to a new study, which suggests treatment for RLS may improve sleep and quality of life for these patients.